晚期支气管肺腺癌一线靶向治疗的疗效对比分析(3)
[4] Thatcher N，Chang A，Parikh P，et al.Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer：results from a randomised placebo-controlled，multicentre study(Iressa Survival Evaluation in Lung Cancer[J].Lancet ......
您现在查看是摘要页，全文长 1908 字符。